Dr Daniel R Monson, D D S | |
110 West Mott Ave, Chamberlain, SD 57325-1244 | |
(605) 734-6028 | |
(605) 734-6029 |
Full Name | Dr Daniel R Monson |
---|---|
Gender | Male |
Speciality | Dentist |
Location | 110 West Mott Ave, Chamberlain, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1740346493 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | M382 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Daniel R Monson, D D S Po Box 26, Chamberlain, SD 57325-1244 Ph: (605) 734-6028 | Dr Daniel R Monson, D D S 110 West Mott Ave, Chamberlain, SD 57325-1244 Ph: (605) 734-6028 |
News Archive
The European Association for the Study of the Liver today publishes their revised Clinical Practice Guidelines (CPGs) on the management of hepatitis C virus infection. The EASL guidelines, which supersede the previous version published in 2011, are designed to help physicians and other healthcare providers optimise their management of patients with acute and chronic HCV.
Disparities in access to health care and education hinder minorities and socioeconomically disadvantaged populations from receiving needed cancer services and often lead to delayed cancer diagnoses.
If you want to increase your chances of living longer, taking cholesterol drugs is an easy way to do it. That's the message from a Harvard study of 4,162 people hospitalized in 350 places in eight countries. It is the first research to show that intense lowering of cholesterol results in a major reduction in deaths and severe heart attacks.
Merck KGaA announced today that it has acquired Suzhou Taizhu Technology Development Co. Ltd. ("Taizhu"), a leading supplier of effect pigments located in Taicang near Shanghai, China. With total revenues of more than € 14 million in 2008 and 300 employees Taizhu is one of the biggest effect pigments companies in the Chinese market. The acquisition is of high strategic importance to the Merck pigments business.
PEPFAR, initiated in 2003, is "the largest global health initiative ever undertaken focused on a single disease," a Washington Post editorial writes, noting, "Now, after four years of work, some 400 interviews and visits to 13 nations, the Institute of Medicine of the National Academy of Sciences has provided [an] examination of this incredibly ambitious program."
› Verified 3 days ago
Dr. Zachary Mccready, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 110 W Mott Ave, Chamberlain, SD 57325 Phone: 605-734-6028 |